Goldman Sachs Future Health Care Equity ETF Rating $34.87 -0.12 (-0.34%) (As of 07/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Goldman Sachs Future Health Care Equity ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GDOC Aggregate RatingModerate Buy2.71Holdings in GDOC have an aggregate rating of Moderate Buy based on 523 analyst ratings issued in the past year covering 35 companies (78.4% of the portfolio).GDOC Aggregate Price Target$39.8714.34% UpsideHigh Prediction$49.18Average Prediction$39.87Low Prediction$29.58Holdings in GDOC have an aggregate price target of $39.87 and a range of $29.58 to $49.18 covering 35 companies (78.4% of the portfolio).GDOC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Goldman Sachs Future Health Care Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 35 GDOC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.12%LLYEli Lilly and Company$805.12-2.0%4.6381 of 5 stars4.64 / 5 stars2.84$858.72 6.7%19Analyst Forecast6.03%BSXBoston Scientific$74.95+0.9%4.7808 of 5 stars4.78 / 5 stars2.95$84.76 13.1%21Earnings ReportAnalyst UpgradeNews Coverage5.03%ISRGIntuitive Surgical$441.30+1.0%4.7674 of 5 stars4.77 / 5 stars2.74$438.74 -0.6%19Insider SellingShort Interest ↓4.44%AMGNAmgen$334.85+0.2%4.4969 of 5 stars4.50 / 5 stars2.52$312.63 -6.6%21Short Interest ↑Analyst Revision4.27%ABBVAbbVie$185.24+1.7%4.8295 of 5 stars4.83 / 5 stars2.87$188.71 1.9%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.62%DHRDanaher$274.13+1.5%4.7182 of 5 stars4.72 / 5 stars2.71$276.88 1.0%17Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓Analyst RevisionNews Coverage3.34%PODDInsulet$193.30+1.3%4.8108 of 5 stars4.81 / 5 stars2.83$239.18 23.7%18Analyst ForecastNews CoverageGap UpHigh Trading Volume3.28%NBIXNeurocrine Biosciences$146.80+0.5%4.7048 of 5 stars4.70 / 5 stars2.78$154.08 5.0%23Upcoming EarningsAnalyst ForecastNews Coverage3.23%HUMHumana$392.63+1.6%4.7351 of 5 stars4.74 / 5 stars2.41$402.60 2.5%22Upcoming EarningsAnalyst ForecastShort Interest ↓3.13%MTDMettler-Toledo International$1,450.08+2.8%4.3291 of 5 stars4.33 / 5 stars2.00$1,301.25 -10.3%8Upcoming EarningsShort Interest ↓Analyst RevisionNews Coverage3.12%COOCooper Companies$93.21+0.6%2.6881 of 5 stars2.69 / 5 stars2.75$111.78 19.9%12Short Interest ↓3.03%ABTAbbott Laboratories$105.23-0.7%4.959 of 5 stars4.96 / 5 stars2.88$120.70 14.7%8Options Volume2.92%BIIBBiogen$211.17-7.2%4.8342 of 5 stars4.83 / 5 stars2.65$286.00 35.4%26Upcoming EarningsAnalyst ForecastShort Interest ↑Gap Down2.90%BMRNBioMarin Pharmaceutical$84.59-1.2%4.8983 of 5 stars4.90 / 5 stars2.55$102.00 20.6%20Upcoming EarningsAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage1.96%ALGNAlign Technology$220.45-2.5%4.8123 of 5 stars4.81 / 5 stars2.50$330.50 49.9%10Earnings ReportAnalyst ForecastNews Coverage1.64%EWEdwards Lifesciences$62.37+4.5%4.9677 of 5 stars4.97 / 5 stars2.41$83.45 33.8%23Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionNews CoverageHigh Trading Volume1.62%IDXXIDEXX Laboratories$469.71-0.2%4.2855 of 5 stars4.29 / 5 stars2.70$585.89 24.7%10Analyst ForecastNews Coverage1.58%ARGXargenx$494.46+1.7%1.0803 of 5 stars1.08 / 5 stars2.90$539.05 9.0%21Earnings ReportAnalyst UpgradeShort Interest ↑News CoverageGap DownHigh Trading Volume1.56%ZBHZimmer Biomet$111.29+0.6%4.6728 of 5 stars4.67 / 5 stars2.29$129.53 16.4%17Positive News1.14%VEEVVeeva Systems$192.55+3.2%4.7028 of 5 stars4.70 / 5 stars2.64$228.27 18.6%22Analyst RevisionNews Coverage1.01%ALNYAlnylam Pharmaceuticals$234.84-1.3%3.3743 of 5 stars3.37 / 5 stars2.67$256.73 9.3%24Upcoming EarningsShort Interest ↑0.95%DXCMDexCom$64.00-40.7%4.9811 of 5 stars4.98 / 5 stars2.87$139.33 117.7%17Earnings ReportAnalyst ForecastNews CoverageGap DownHigh Trading Volume0.78%PCVXVaxcyte$84.05+0.5%0.2295 of 5 stars0.23 / 5 stars3.00$78.50 -6.6%4Insider SellingNews Coverage0.70%GMABGenmab A/S$28.38+0.9%3.9455 of 5 stars3.95 / 5 stars2.42$49.50 74.4%12Upcoming Earnings0.65%WSTWest Pharmaceutical Services$284.79+2.8%4.9266 of 5 stars4.93 / 5 stars2.75$442.75 55.5%4Earnings ReportOptions VolumeAnalyst RevisionNews CoverageHigh Trading Volume0.64%CGONCG Oncology$33.07+0.2%1.0416 of 5 stars1.04 / 5 stars3.00$64.00 93.5%5Lockup ExpirationNews Coverage0.60%ITCIIntra-Cellular Therapies$80.39-0.6%4.6796 of 5 stars4.68 / 5 stars2.83$94.83 18.0%12Short Interest ↓News Coverage0.59%RAREUltragenyx Pharmaceutical$44.86-0.4%4.3748 of 5 stars4.37 / 5 stars2.93$86.50 92.8%14Upcoming EarningsAnalyst Forecast0.56%NTRANatera$102.67+0.5%1.3431 of 5 stars1.34 / 5 stars3.00$101.19 -1.4%16Upcoming EarningsInsider SellingNews Coverage0.54%ROIVRoivant Sciences$10.80+0.6%3.0371 of 5 stars3.04 / 5 stars2.90$17.10 58.3%100.52%TMDXTransMedics Group$140.49-3.8%2.1853 of 5 stars2.19 / 5 stars2.88$146.38 4.2%8Upcoming EarningsGap Up0.49%XENEXenon Pharmaceuticals$43.96+0.3%2.2496 of 5 stars2.25 / 5 stars3.00$59.11 34.5%9Options VolumeNews CoveragePositive News0.47%MLTXMoonLake Immunotherapeutics$44.77-0.3%1.2575 of 5 stars1.26 / 5 stars2.77$79.00 76.5%13Positive News0.45%BPMCBlueprint Medicines$112.19-1.3%0.604 of 5 stars0.60 / 5 stars2.63$116.33 3.7%16Upcoming EarningsShort Interest ↑Analyst RevisionNews Coverage0.44%IRTCiRhythm Technologies$88.34-6.9%2.744 of 5 stars2.74 / 5 stars3.00$130.88 48.1%7Upcoming Earnings This page (NYSEARCA:GDOC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Goldman Sachs Future Health Care Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Goldman Sachs Future Health Care Equity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
